EUVIMEDEUVIMED entdecken
Fallbericht

Severe eczema in Wiskott–Aldrich syndrome‐related disorder successfully treated with dupilumab

Fatmah Alzahrani iD, Holly K Miller, Keith Sacco, Elizabeth Dupuy

Pediatric Dermatology · 2024

DOI: 10.1111/pde.15397 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Pediatric Dermatology, 2024. Verfasst von Fatmah Alzahrani und 3 weiteren Autor:innen. Beteiligte Einrichtung: Division of Dermatology, Phoenix Children's Hospital, Phoenix, Arizona, USA. Hauptthemen laut MEDLINE: Wiskott-Aldrich Syndrome, Dermatitis, Atopic, Eczema. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 5 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Treatment of severe eczema in patients with primary immunodeficiencies can be particularly challenging as there are no guidelines with regards to these conditions. Dupilumab is an interleukin (IL)‐4Rα antagonist that inhibits both IL‐4 and IL‐13 and is approved for the treatment of atopic dermatitis in pediatric patients. In this report, we describe a patient with a case of severe eczema in the context of Wiskott–Aldrich syndrome‐related disorder, who was successfully treated with dupilumab.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Wiskott-Aldrich SyndromeDermatitis, AtopicEczemaHumansChildAntibodies, Monoclonal, HumanizedTreatment OutcomeSeverity of Illness Index

Stichwörter der Autor:innen

atopic dermatitisdermatitis-eczemas NOSeczemaimmunodeficiencytherapysystemic

Substanzen

dupilumabAntibodies, Monoclonal, Humanized

Autor:innen und Institutionen

  • Division of Dermatology, Phoenix Children's Hospital, Phoenix, Arizona, USA.
  • Mayo Clinic College of Medicine and Science, Scottsdale, Arizona, USA.
  • Center for Cancer and Blood Disorders, Phoenix Children's Hospital, Phoenix, Arizona, USA.
  • The University of Arizona College of Medicine-Phoenix, Phoenix, Arizona, USA.
  • Division of Pulmonology, Section of Allergy-Immunology, Phoenix Children's Hospital, Phoenix, Arizona, USA.

ORCID-Profile: Fatmah Alzahrani

Zitieren

APA

Alzahrani, F., Miller, H. K., Sacco, K., & Dupuy, E. (2024). Severe eczema in Wiskott–Aldrich syndrome‐related disorder successfully treated with dupilumab. Pediatric Dermatology. https://doi.org/10.1111/pde.15397

Vancouver

Alzahrani F, Miller HK, Sacco K, Dupuy E. Severe eczema in Wiskott–Aldrich syndrome‐related disorder successfully treated with dupilumab. Pediatric Dermatology. 2024. doi:10.1111/pde.15397

BibTeX
@article{Alzahrani2024,
  author = {Alzahrani, Fatmah and Miller, Holly K and Sacco, Keith and Dupuy, Elizabeth},
  title = {Severe eczema in Wiskott–Aldrich syndrome‐related disorder successfully treated with dupilumab},
  journal = {Pediatric Dermatology},
  year = {2024},
  doi = {10.1111/pde.15397}
}
Kostenlos starten →